• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰乐菌素在正常犬体内的药代动力学分析。

A pharmacokinetic analysis of tylosin in the normal dog.

作者信息

Weisel M K, Powers J D, Powers T E, Baggot J D

出版信息

Am J Vet Res. 1977 Feb;38(2):273-5.

PMID:842925
Abstract

Studies were conducted to determine certain kinetic variables for tylosin in the normal dog. These variables were determined by pharmacokinetic analysis, measuring the decrease in serum concentration of tylosin activity in 3 separate experiments. Tylosin, given as a single intravenous dose of 10 mg of tylosin activity/kg of body weight, was calculated to have an elimination half life (t1/2beta) of 54 minutes and was no longer detectable in the serum by assay methods at about 270 minutes. In addition, tylosin appeared to be highly distributed with an apparent volume of distribution of about 1.7 L/kg and a tissue-to-plasma ratio of about 0.7. The body clearance of tylosin was calculated to be about 22 ml/kg minute. A separate multiple-dose intravenous experiment with the same dose per injection was conducted and showed similar results. Also, single intramuscular injection of 10 mg of tylosin activity/kg showed tylosin to peak after injection in the serum at 30 minutes, attaining a concentration of approximately 1.5 mug/ml. This concentration was maintained through 60 minutes and decreased slowly through 540 minutes. Data generated through 17 clinical cases indicated that the minimum inhibitory concentration for tylosin in Pasteurella spp tested was about 6.25 mcs/ml and for hemolytic Staphylococcus spp tested greater than or equal to 0.4 mug/ml. Thus, it would appear that tylosin, given at the recommended dose (6.6 to 11.0 mg tylosin activity/kg of body weight once or twice per day), would produce serum levels insufficient to treat all Pasteurella spp and some hemolytic Staphylococcus spp tested since a serum level of tylosin at slightly higher than 1 mug/ml for about 30 minutes was achieved in this study.

摘要

开展了多项研究以确定泰乐菌素在正常犬体内的某些动力学变量。这些变量通过药代动力学分析来确定,在3个独立实验中测量泰乐菌素活性的血清浓度下降情况。以10mg泰乐菌素活性/kg体重的单次静脉注射剂量给药后,计算得出泰乐菌素的消除半衰期(t1/2β)为54分钟,约270分钟后通过检测方法在血清中不再可检测到。此外,泰乐菌素似乎分布广泛,表观分布容积约为1.7L/kg,组织与血浆的比率约为0.7。泰乐菌素的机体清除率经计算约为22ml/kg·分钟。进行了一次单独的多剂量静脉注射实验,每次注射剂量相同,结果相似。同样,单次肌肉注射10mg泰乐菌素活性/kg后,血清中的泰乐菌素在注射后30分钟达到峰值,浓度约为1.5μg/ml。该浓度在60分钟内保持稳定,并在540分钟内缓慢下降。通过17例临床病例得出的数据表明,所检测的巴斯德氏菌属中泰乐菌素的最低抑菌浓度约为6.25μg/ml,所检测的溶血性葡萄球菌属中泰乐菌素的最低抑菌浓度大于或等于0.4μg/ml。因此,似乎按照推荐剂量(6.6至11.0mg泰乐菌素活性/kg体重,每天一次或两次)给药时,泰乐菌素产生的血清水平不足以治疗所有所检测的巴斯德氏菌属和一些溶血性葡萄球菌属,因为在本研究中,泰乐菌素的血清水平略高于1μg/ml约30分钟。

相似文献

1
A pharmacokinetic analysis of tylosin in the normal dog.泰乐菌素在正常犬体内的药代动力学分析。
Am J Vet Res. 1977 Feb;38(2):273-5.
2
Pharmacokinetic interpretation of erythromycin and tylosin activity in serum after intravenous administration of a single dose to cows.单次静脉注射给药后奶牛血清中红霉素和泰乐菌素活性的药代动力学解释
Res Vet Sci. 1976 Nov;21(3):318-23.
3
Disposition of tylosin in goats.泰乐菌素在山羊体内的处置。
Dtsch Tierarztl Wochenschr. 1991 Dec;98(12):451-3.
4
Disposition of tylosin in goats.泰乐菌素在山羊体内的处置情况。
Br Vet J. 1991 May-Jun;147(3):207-15. doi: 10.1016/0007-1935(91)90045-O.
5
Single intravenous and multiple dose pharmacokinetics of gentamicin in healthy llamas.庆大霉素在健康美洲驼中的单次静脉注射及多剂量药代动力学
Am J Vet Res. 1996 Aug;57(8):1193-9.
6
Tylosin concentrations in rat serum and lung tissue after administration in drinking water.
Lab Anim Sci. 1987 Aug;37(4):468-70.
7
Pharmacokinetics of tylosin in broiler chickens.泰乐菌素在肉鸡体内的药代动力学
Pol J Vet Sci. 2002;5(3):127-30.
8
Disposition kinetics of tylosin administered intravenously and intramuscularly in desert sheep and Nubian goats.泰乐菌素在沙漠绵羊和努比亚山羊体内静脉注射及肌肉注射后的处置动力学
Vet J. 1999 Nov;158(3):210-5. doi: 10.1053/tvjl.1999.0374.
9
Pharmacokinetics and tissue concentrations of tylosin in selected avian species.泰乐菌素在选定禽类中的药代动力学和组织浓度
Am J Vet Res. 1982 Oct;43(10):1807-10.
10
NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.国家毒理学计划关于水合氯醛(化学物质登记号:302-17-0)毒性和代谢研究的技术报告。通过灌胃法给予F344/N大鼠和B6C3F1小鼠。
Toxic Rep Ser. 1999 Aug(59):1-66, A1-E7.

引用本文的文献

1
Recovery of Fecal Microbiome and Bile Acids in Healthy Dogs after Tylosin Administration with and without Fecal Microbiota Transplantation.泰乐菌素给药并联合或不联合粪便微生物群移植后健康犬粪便微生物组和胆汁酸的恢复情况
Vet Sci. 2022 Jun 27;9(7):324. doi: 10.3390/vetsci9070324.
2
Efficacy of two low-dose oral tylosin regimens in controlling the relapse of diarrhea in dogs with tylosin-responsive diarrhea: a prospective, single-blinded, two-arm parallel, clinical field trial.两种低剂量口服泰乐菌素方案对泰乐菌素敏感性腹泻犬腹泻复发的控制效果:一项前瞻性、单盲、双臂平行的临床现场试验。
Acta Vet Scand. 2014 Aug 6;56(1):43. doi: 10.1186/s13028-014-0043-5.